🇺🇸 FDA
Company

Tonix

Tonix Pharmaceuticals Holding

TNXP pharma USA

Quick answer

Tonix is a pharma company (TNXP) headquartered in BERKELEY HEIGHTS, NJ, USA with 24 tracked pipeline programs.

Pipeline (24)

project

TNX-102 SL

Primary Fibromyalgia

Phase 3 · small_molecule · completed

1 trials project

TNX-102 SL

PTSD

Phase 3 · small_molecule · terminated

6 trials project

TNX-102 SL

Fibromyalgia

Phase 3 · small_molecule · completed

2 trials project

TNX-102 SL 2.8mg

Primary Fibromyalgia

Phase 3 · small_molecule · completed

1 trials project

TNX-102 SL 5.6 mg

PTSD

Phase 3 · small_molecule · completed

1 trials project

TNX-102 SL Tablet 2.8 mg

Primary Fibromyalgia

Phase 3 · small_molecule · completed

1 trials project

TNX-102 SL Tablet, 2.8 mg

Fibromyalgia

Phase 3 · small_molecule · terminated

1 trials project

TNX-102 SL Tablet, 2.8mg

Fibromyalgia

Phase 3 · small_molecule · completed

1 trials project

TNX-102 SL Tablet, 5.6 mg

Fibromyalgia

Phase 3 · small_molecule · completed

1 trials project

Cyclobenzaprine HCl

Acute Stress Reaction

Phase 2 · small_molecule · active

1 trials project

TNX-102 SL

Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection

Phase 2 · small_molecule · completed

1 trials project

TNX-1300

Cocaine Intoxication

Phase 2 · small_molecule · terminated

1 trials project

TNX-1500

Kidney Transplant

Phase 2 · small_molecule · active

1 trials project

TNX-1900

Chronic Migraine

Phase 2 · small_molecule · completed

1 trials project

TNX-201

Tension-Type Headache

Phase 2 · small_molecule · completed

1 trials project

TNX-601 ER

Depression

Phase 2 · small_molecule · completed

1 trials project

Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor

Pain, Face

Phase 1 · small_molecule · completed

1 trials project

Intranasal Oxytocin (IN-OXT)

Vasopressin Deficiency

Phase 1 · small_molecule · active

1 trials project

SL TNX-102 2.4 mg at pH 3.5

Healthy Adults

Phase 1 · small_molecule · completed

1 trials project

SL TNX-102 at 2.4 mg

Healthy Adults

Phase 1 · small_molecule · completed

1 trials project

TNX-102 SL

Healthy Subjects (HS)

Phase 1 · small_molecule · completed

1 trials project

TNX-102 SL

Healthy Subjects

Phase 1 · small_molecule · completed

1 trials project

TNX-102 SL 5.6 mg

Healthy Subjects

Phase 1 · small_molecule · completed

1 trials project

TNX-102 SL Tablet

Pharmakokinetic

Phase 1 · small_molecule · active

1 trials

Drugs (3)

drug

cyclobenzaprine hydrochloride

CYCLOBENZAPRINE HYDROCHLORIDE

 drug

sumatriptan

IMITREX

 drug

sumatriptan succinate

SUMATRIPTAN SUCCINATE

Patents (8)

patent

US 12383733

Iontophoresis-based patch type medicine absorption device

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12365879

Synthetic chimeric poxviruses

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12304901

Selective ligands for tau aggregates

Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12156864

Analogs of cyclobenzaprine and amitryptilene

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12156897

Magnesium-containing oxytocin formulations and methods of use

Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12097183

Pharmaceutical composition for treating migraine

Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12090139

Formulations comprising triptan compounds

Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11998516

Methods and compositions for treating depression using cyclobenzaprine

Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)